中文版 | English
题名

Blockade of endothelin receptors mitigates SARS-CoV-2-induced osteoarthritis

作者
通讯作者Yuan, Shuofeng; Wen, Chunyi
发表日期
2024-09-01
DOI
发表期刊
ISSN
2058-5276
摘要
["Joint pain and osteoarthritis can occur as coronavirus disease 2019 (COVID-19) sequelae after infection. However, little is known about the damage to articular cartilage. Here we illustrate knee joint damage after wild-type, Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in vivo. Rapid joint injury with cystic lesions at the osteochondral junction was observed in two patients with post-COVID osteoarthritis and recapitulated in a golden Syrian hamster model. SARS-CoV-2-activated endothelin-1 signalling increased vascular permeability and caused viral spike proteins leakage into the subchondral bone. Osteoclast activation, chondrocyte dropout and cyst formation were confirmed histologically. The US Food and Drug Administration-approved endothelin receptor antagonist, macitentan, mitigated cystic lesions and preserved chondrocyte number in the acute phase of viral infection in hamsters. Delayed macitentan treatment at post-acute infection phase alleviated chondrocyte senescence and restored subchondral bone loss. It is worth noting that it could also attenuate viral spike-induced joint pain. Our work suggests endothelin receptor blockade as a novel therapeutic strategy for post-COVID arthritis.","Endothelin-1 activation after SARS-CoV-2 infection leads to vascular permeability, chondrocyte senescence, osteoclast activation and cyst formation in affected joints of hamsters, which can be alleviated using macitentan. Joint injury was also seen in two patients after COVID-19 infection."]
相关链接[来源记录]
收录类别
语种
英语
学校署名
其他
资助项目
Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund (HMRF)["16172691","07210107"] ; Food and Health Bureau, The Government of the Hong Kong Special Administrative Region["151061/20M","PolyU15100821M","15100324","C7060-21G","T11-709/21-N"] ; National Natural Science Foundation of China (NSFC)["N_PolyU 520/20","N_HKU767/22","MHP/011/20"] ; Innovation and Technology Commission["2021YFC0866100","2023YFC3041600","32322087","32300134"] ; National Key Research and Development Program of China[I2022A006]
WOS研究方向
Microbiology
WOS类目
Microbiology
WOS记录号
WOS:001310046300001
出版者
来源库
Web of Science
引用统计
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/828904
专题南方科技大学医学院_生物化学系
作者单位
1.Hong Kong Polytech Univ, Dept Biomed Engn, Hong Kong, Peoples R China
2.Univ Hong Kong, Li Ka Shing Fac Med, Sch Clin Med, Dept Microbiol,State Key Lab Emerging Infect Dis, Hong Kong, Peoples R China
3.Univ Hong Kong, Li Ka Shing Fac Med, Sch Clin Med, Dept Orthopaed & Traumatol, Hong Kong, Peoples R China
4.Southern Univ Sci & Technol, Dept Biochem, Sch Med, Shenzhen, Peoples R China
5.Hong Kong Baptist Univ, State Key Lab Environm & Biol Anal, Hong Kong, Peoples R China
6.Univ Hong Kong, Shenzhen Hosp, Dept Infect Dis & Microbiol, Shenzhen, Peoples R China
7.Ctr Virol Vaccinol & Therapeut, Hong Kong Sci & Technol Pk, Hong Kong, Peoples R China
8.Hong Kong Polytech Univ, Res Inst Smart Ageing, Hong Kong, Peoples R China
推荐引用方式
GB/T 7714
Au, Man Ting,Ni, Junguo,Tang, Kaiming,et al. Blockade of endothelin receptors mitigates SARS-CoV-2-induced osteoarthritis[J]. NATURE MICROBIOLOGY,2024.
APA
Au, Man Ting.,Ni, Junguo.,Tang, Kaiming.,Wang, Wei.,Zhang, Lanlan.,...&Wen, Chunyi.(2024).Blockade of endothelin receptors mitigates SARS-CoV-2-induced osteoarthritis.NATURE MICROBIOLOGY.
MLA
Au, Man Ting,et al."Blockade of endothelin receptors mitigates SARS-CoV-2-induced osteoarthritis".NATURE MICROBIOLOGY (2024).
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Au, Man Ting]的文章
[Ni, Junguo]的文章
[Tang, Kaiming]的文章
百度学术
百度学术中相似的文章
[Au, Man Ting]的文章
[Ni, Junguo]的文章
[Tang, Kaiming]的文章
必应学术
必应学术中相似的文章
[Au, Man Ting]的文章
[Ni, Junguo]的文章
[Tang, Kaiming]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。